An Act amending the act of October 24, 2018 (P.L.719, No.112), known as the Patient Test Result Information Act, further providing for definitions; providing for Lyme disease testing disclosure; and imposing duties on health care practitioners.

SB 826 amends Pennsylvania's Patient Test Result Information Act to require clinical laboratories to notify healthcare practitioners when reporting Lyme disease test results. The notice must inform practitioners that Lyme tests can be inaccurate and advise patients to consult their provider about symptoms and retesting if needed. Healthcare practitioners must then provide this exact notice to patients when delivering their test results. The bill directly affects Lyme disease patients, healthcare providers, and clinical laboratories in Pennsylvania. It adds a specific disclosure requirement without changing existing professional duties to inform patients about test results.